Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jennifer J. Rhodes currently holds 11,280 shares of Adamas Pharmaceuticals Inc (ADMS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jennifer J. Rhodes has been a net seller of ADMS stock. They have purchased $0 and sold $2.4M worth of shares.
Jennifer J. Rhodes's most recent insider trade was on Mar 25, 2026, when they sold 3,844 shares at $21.47 per share.
Jennifer J. Rhodes serves as Executive at Adamas Pharmaceuticals Inc (ADMS). They have executed 48 insider transactions totaling $2.4M over their tenure at the company.
Jennifer J. Rhodes holds the position of Executive at Adamas Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Jennifer J. Rhodes has shown a selling trading pattern, with $0 in total purchases and $2.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jennifer J. Rhodes was on Jan 21, 2014, when they sold $714.9K worth of MDVN shares. This transaction involved 9,400 shares at $76.05 per share.
Jennifer J. Rhodes currently owns 11,280 shares of Adamas Pharmaceuticals Inc (ADMS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jennifer J. Rhodes's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jennifer J. Rhodes has 48 Form 4 filings on record as an insider at Adamas Pharmaceuticals Inc.
Set alerts for Jennifer J. Rhodes and 40,000+ other insiders.